文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

巯基化壳聚糖修饰的载紫杉醇 PMMA 纳米粒对不同正常细胞和癌细胞系的区分作用。

Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines.

机构信息

Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Nanomedicine. 2010 Oct;6(5):689-97. doi: 10.1016/j.nano.2010.01.011. Epub 2010 Feb 18.


DOI:10.1016/j.nano.2010.01.011
PMID:20172052
Abstract

UNLABELLED: The aim of the present work was to prepare and characterize poly(methyl methacrylate) nanoparticles coated by chitosan-glutathione conjugate so as to encapsulate insoluble anticancer drugs. Nanoparticles were synthesized through radical polymerization of methyl methacrylate initiated by cerium (IV) ammonium nitrate. Paclitaxel (PTX), a model anticancer drug, was encapsulated in nanoparticles with a maximal encapsulation efficiency of 98.27%. These nanoparticles showed sustained in vitro release of the incorporated PTX (75% of the loaded dose was released in 10 days). All nanoparticles had positive charge and were spherical, with a size range of about 130-250 nm. The PTX-loaded nanoparticles showed cytotoxicity for NIH 3T3 and T47D breast carcinoma cells, along with no cytotoxicity for two colon cell lines (HT29, Caco2). FROM THE CLINICAL EDITOR: The aim of this work was to prepare and characterize poly(methyl methacrylate) nanoparticles coated by chitosan-glutathione conjugate in an effort to encapsulate Paclitaxel as a model of insoluble anticancer drugs. These nanoparticles showed sustained in vitro drug release.

摘要

未加标签:本工作旨在制备并表征壳聚糖-谷胱甘肽缀合物包覆的聚甲基丙烯酸甲酯纳米粒子,以包裹难溶性抗癌药物作为模型药物。纳米粒子通过硝酸铈(IV)铵引发的甲基丙烯酸甲酯自由基聚合合成。紫杉醇(PTX)是一种模型抗癌药物,其包封效率最高可达 98.27%。这些纳米粒子表现出对所载 PTX 的持续体外释放(10 天内释放了 75%的载药量)。所有纳米粒子均带正电荷,呈球形,粒径约为 130-250nm。载有 PTX 的纳米粒子对 NIH 3T3 和 T47D 乳腺癌细胞具有细胞毒性,而对两种结肠细胞系(HT29、Caco2)没有细胞毒性。

临床编辑按:本工作旨在制备并表征壳聚糖-谷胱甘肽缀合物包覆的聚甲基丙烯酸甲酯纳米粒子,以包裹紫杉醇作为难溶性抗癌药物的模型药物。这些纳米粒子显示出持续的体外药物释放。

相似文献

[1]
Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines.

Nanomedicine. 2010-2-18

[2]
Multimeric System of RGD-Grafted PMMA-Nanoparticles as a Targeted Drug- Delivery System for Paclitaxel.

Curr Pharm Des. 2017

[3]
Curcuminoid-loaded poly(methyl methacrylate) nanoparticles for cancer therapy.

Int J Nanomedicine. 2018-3-15

[4]
Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.

J Control Release. 2006-3-10

[5]
Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.

Int J Biol Macromol. 2017-5

[6]
Self-aggregated nanoparticles of linoleic acid-modified glycol chitosan conjugate as delivery vehicles for paclitaxel: preparation, characterization and evaluation.

J Biomater Sci Polym Ed. 2015

[7]
Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation.

Int J Nanomedicine. 2011-1-12

[8]
Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.

Chem Pharm Bull (Tokyo). 2015

[9]
Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.

Mol Pharm. 2015-12-7

[10]
Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.

Biomacromolecules. 2009-3-9

引用本文的文献

[1]
Oral Bioavailability Enhancement of Anti-Cancer Drugs Through Lipid Polymer Hybrid Nanoparticles.

Pharmaceutics. 2025-3-17

[2]
Enhanced in vivo Stability and Antitumor Efficacy of PEGylated Liposomes of Paclitaxel Palmitate Prodrug.

Int J Nanomedicine. 2024

[3]
anti-prostate adenocarcinoma and lung cancer studies of phenoxyaniline--poly(methyl methacrylate) based nanocomposites controlled radical polymerization.

Nanoscale Adv. 2023-9-14

[4]
Harnessing Lipid Polymer Hybrid Nanoparticles for Enhanced Oral Bioavailability of Thymoquinone: In Vitro and In Vivo Assessments.

Polymers (Basel). 2022-9-6

[5]
The Potential of Chitosan in Nanomedicine: An Overview of the Cytotoxicity of Chitosan Based Nanoparticles.

Front Pharmacol. 2022-5-4

[6]
The anticancer efficacy of paclitaxel liposomes modified with low-toxicity hydrophobic cell-penetrating peptides in breast cancer: an and evaluation.

RSC Adv. 2018-7-2

[7]
Thiolated Nanoparticles for Biomedical Applications: Mimicking the Workhorses of Our Body.

Adv Sci (Weinh). 2022-1

[8]
Thiolated-Polymer-Based Nanoparticles as an Avant-Garde Approach for Anticancer Therapies-Reviewing Thiomers from Chitosan and Hyaluronic Acid.

Pharmaceutics. 2021-6-8

[9]
Targeted Co-Delivery of Docetaxel and cMET siRNA for Treatment of Mucin1 Overexpressing Breast Cancer Cells.

Adv Pharm Bull. 2018-8

[10]
Fabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44(+) cancer cells.

Daru. 2016-7-29

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索